Britain’s second coronavirus wave appears to have flatlined, with cases increasing just 0.06 per cent in the last week, new figures have today revealed.
In another sign the second wave is slowing, the Government announced another 21,363 new lab-confirmed Covid cases in the UK.
Though the figure appears high, it is a small increase from last Monday’s figure of 21,350 new cases.
It brings the total number of cases in the UK to 1,390,681 since the start of the pandemic.
The Government also announced a further 213 people had died within 28 days of testing positive for Covid-19 as of Monday – up 9.8 per cent from from last Monday’s figure of 194.
The latest death figure brings the UK total to 52,147 since the start of the pandemic.
However, separate data from the UK’s statistic agencies show the figure to be more than 67,000 deaths involving Covid-19 in the UK.
These include deaths where Covid-19 has been mentioned on the death certificate, together with additional data on deaths that have occurred in recent days.
It comes as Health Secretary Matt Hancock revealed tonight that Britain has secured five million doses of Moderna’s coronavirus vaccine after UK officials scrambled to strike a last-minute deal with the US firm.
In another sign lockdown measures are working, new Covid case numbers were recorded at 21,363 in the UK. The figure is new lab-confirmed cases recorded as of 9am today
The Government also announced a further 213 people had died within 28 days of testing positive for Covid-19 as of Monday – up 9.8 per cent from from last Monday’s figure of 194
But the jab – which was revealed today to be 94.5 per cent effective at preventing people from getting infected with Covid-19 – needs to be taken in two shots, meaning the five million doses will only vaccinate two-and-a-half million Brits.
Speaking at a Downing Street press conference tonight, Mr Hancock said the vaccine won’t be available in the UK until next spring because the Massachusetts-based firm needs to drastically ramp up its supply chain.
But Americans will likely get their hands on 20 million doses before the new year.
The UK has already secured 40 million doses of a different vaccine from Pfizer, which uses the same technology as Moderna and was last week found to be 90 per cent effective.
Speaking at a Downing Street press conference tonight, Mr Hancock said the vaccine won’t be available in the UK until next spring because the Massachusetts-based firm needs to drastically ramp up its supply chain.
Moderna’s vaccine works in the same way as the one developed by Pfizer and BioNTech, by using genetic material called RNA from the coronavirus to trick the body into making the ‘spike’ proteins that the virus uses to latch onto cells inside the body
But the Government did not place orders for Moderna’s jab at the same time, despite it being cheaper and easier to store than Pfizer’s.
It meant the British Government was left flat-footed when the company announced its initial findings this morning. Mr Hancock dodged questions over why the UK had not bought Moderna’s vaccine ahead of time, insisting it was ‘really good news’ that No10 had managed to secure any at all.
He also paid tribute to the UK’s Vaccine Taskforce, chaired by Kate Bingham, and Business Secretary Alok Sharma for their ‘great job’ in wrangling a last-minute deal with the biotech firm.
Mr Hancock said he was ‘delighted’ that No10 had expanded its portfolio of vaccines from six to seven and repeatedly said the jab won’t be manufactured in Europe until the spring. Labour MP Bill Esterson said the failure to pre-order any doses of the Moderna vaccine represented ‘mistake after mistake after mistake by the UK Government.’
The Health Secretary hailed both Pfizer and Moderna’s vaccine trial results as a ‘candle of hope’, but warned the UK’s high infection and death rates made it ‘painfully clear the virus remains a potent threat’ – 25,000 people are catching the disease every day and 413 are dying.
Moderna’s results show 95 out of more than 25,000 participants caught the coronavirus in the trial.
Only five out of the 95 had actually been given the vaccine, while the other 90 were in a placebo group and given a fake jab.
And nobody in the vaccine group got seriously ill with Covid-19, compared to 11 in the placebo group, who were given a fake vaccine to compare against the real one.
The results suggest the vaccine significantly reduces the risk of people testing positive for coronavirus or getting sick with Covid-19.
The US has already struck a $1.5billion (£1.16bn) deal for 100m doses, while the EU has an ‘unsigned’ deal for 160m doses.
Japan, Canada, Switzerland, Qatar and Israel have all also secured deals, while the company continues ‘discussions with a number of countries’.
Moderna is expected to manufacture 20m doses this year for the US before beginning global delivery next year.
The jab is expected to cost $15.25 (£11.57) per dose, so $30.50 (£23.14) per person, which is slightly cheaper than the $19.50 (£14.79) per dose charged to the US by Pfizer.
Moderna’s may be cheaper to distribute, however, because it can be kept in a fridge for up to a month and transported in normal freezers at -20°C (-4°F). Nations will not need to buy expensive specialist freezers or the global supply of dry ice, which experts warned would be a drawback of Pfizer’s jab which must be kept at -70°C (-94°F).
Moderna said it will apply for a licence from the US Food & Drug Administration within weeks, but it is unclear whether it will apply to the UK.
British drug regulator, the MHRA, is in the midst of an ongoing review of the vaccine. MPs today criticised No10 for failing to buy the vaccine, accusing ministers of ‘mistake after mistake after mistake’.
Christmas still in peril as Matt Hancock warns it is ‘too early’ to know if coronavirus case numbers will fall enough to lift the national lockdown on December 2
Jack Maidment and David Wilcock for MailOnline
Health Secretary Matt Hancock today warned it is ‘too early’ to know if coronavirus case numbers will have fallen enough to lift the England-wide lockdown on December 2.
Mr Hancock said ‘most of’ the positive tests which are emerging across the country now likely originated before the national shutdown started.
Health officials said this afternoon that ‘if the lockdown is working’ then they should start to see case numbers start to fall ‘over the next week’.
Mr Hancock said ministers ‘absolutely hope to be able to replace the national lockdown with a tiered system’ next month – but he stopped short of guaranteeing that will happen as he placed Christmas in peril.
Matt Hancock, pictured in Downing Street this afternoon, said ministers ‘absolutely hope to be able to replace the national lockdown with a tiered system’ next month – but he stopped short of guaranteeing that will happen
Boris Johnson has made clear that the regulations underpinning the national lockdown will expire on December 2 and MPs will be given a say on what happens next.
However, there are fears that if case numbers are still high as the four-week deadline approaches then the PM could be forced into trying to extend the shutdown.
That would spark a furious Tory rebellion, with many of the PM’s backbenchers adamant they will not agree to keeping the national measures in place.
Appearing at a Downing Street press conference, Mr Hancock was asked whether lockdown will be extended if case numbers are still continuing to rise.
He said: ‘The answer is that it is too early for us to know what the number of cases will be as we come to the end of the current lockdown.
‘But what I would say is that at the moment most of the tests that we are getting back and most of the positive cases are from around the time that the lockdown came in.
‘And so we are yet to see in the data, and it is too early to expect to see in the data, the impact of the second lockdown.
‘But we absolutely hope to be able to replace the national lockdown with a tiered system similar to what we had before.
‘But we of course are assessing that and assessing how we can make sure that that will be effective.’
Dr Susan Hopkins, a Public Health England director who is advising the Government’s coronavirus response, said officials should start to see if lockdown is working ‘over the next week’.
Speaking alongside Mr Hancock, she said: ‘The key issue for us is making sure that cases start to fall and we expect if the lockdown is working, and we are all doing the best we can to have reduced social contact with other people, that we will start to see cases decline over the next week.
‘We expect it will be longer to see hospital admissions [fall], another week or so, but I think as long as we start to see cases decline then we can start making a judgement about what are the right decisions that we make and what are the opening up decisions that happen on December 2.’
Dr Hopkins signalled there could be a possible tightening of restrictions at the bottom end of the English tier system if and when the Government decides to reintroduce it.
She warned this could be required to increase its effectiveness until Covid-19 vaccines become widely available.
Dr Susan Hopkins said ‘if the lockdown is working’ then officials should start to see case numbers falling ‘over the next week’
Asked what might happen after the lockdown ends on December 2, she said: ‘We have recognised that the tiering of the country has had a different effect in each area.
‘Tier 3 and especially Tier 3 plus in the north has had an effect on reducing the numbers of cases in the north west and we can see in the north west a declining number of cases now.
‘Tier 2 seemed to hold in some areas and not so well in others so really it depends on how fast transmissions are occurring and how well the individuals in the population are taking that advice in.
‘We are seeing very little effect from Tier 1 and I think when we look at what tiers may be there in future we will have to think about strengthening them in order to get us through the winter months until the vaccine is available for everyone.’